SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027177
Filing Date
2021-05-13
Accepted
2021-05-13 06:02:41
Documents
64
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sybx-10q_20210331.htm   iXBRL 10-Q 2024817
2 EX-31.1 sybx-ex311_6.htm EX-31.1 16795
3 EX-31.2 sybx-ex312_7.htm EX-31.2 16734
4 EX-32.1 sybx-ex321_8.htm EX-32.1 6980
5 EX-32.2 sybx-ex322_9.htm EX-32.2 6961
  Complete submission text file 0001564590-21-027177.txt   6612027

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sybx-20210331.xsd EX-101.SCH 41381
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sybx-20210331_cal.xml EX-101.CAL 38215
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sybx-20210331_def.xml EX-101.DEF 144017
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20210331_lab.xml EX-101.LAB 333291
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20210331_pre.xml EX-101.PRE 261091
11 EXTRACTED XBRL INSTANCE DOCUMENT sybx-10q_20210331_htm.xml XML 1149806
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37566 | Film No.: 21917026
SIC: 2834 Pharmaceutical Preparations